What is Avasa?
Founded in 2018, Avasa specializes in the development of advanced medical hardware designed to standardize and simplify complex reconstructive microsurgery. The company's flagship innovation, the Avasa Coupler, serves as a critical tool for surgeons, aiming to reduce procedural variability and improve patient outcomes in delicate vascular operations. As a deep-tech entity, Avasa operates at the intersection of surgical precision and engineering excellence, positioning itself as a key player in the global health-tech landscape. The firm's focus on high-impact, scalable medical solutions has attracted a diverse group of institutional backers and angel networks committed to fostering innovation within the Asia-Pacific medical device ecosystem.
How much funding has Avasa raised?
Avasa has raised a total of $1.6M across 1 funding round:
Other Financing Round
$1.6M
Other Financing Round (2023): $1.6M with participation from Pacific Channel, The NZGCP, and Brisbane Angels
Key Investors in Avasa
Pacific Channel
A leading Asia-Pacific funds management firm specializing in deep-tech and venture capital, with a strong focus on health and environmental innovation.
The NZGCP
A government-backed investment entity providing critical support for New Zealand innovators and early-stage technology companies.
Brisbane Angels
Australia's largest angel investing group, connecting experienced investors with high-growth startups to drive sustainable business advantages.
What's next for Avasa?
With the recent capital injection, Avasa is poised to execute its go-to-market strategy for the Avasa Coupler. The company's roadmap includes regulatory milestones, clinical validation, and the establishment of distribution channels across international markets. By focusing on the standardization of arterial reconnections, Avasa is well-positioned to capture significant market share in the reconstructive surgery segment. Future growth will likely center on expanding the product portfolio and deepening partnerships with surgical centers of excellence, ensuring that their technological advancements become the new standard of care in microsurgical environments.
See full Avasa company page
